How to cite item

Complete video-assisted thoracoscopic surgery for pulmonary sequestration

  
@article{JTD840,
	author = {Jian-Fei Shen and Xiao-Xue Zhang and Shu-Ben Li and Zhi-Hua Guo and Zhi-Qiang Xu and Xiao-Sun Shi and Jian-Xing He},
	title = {Complete video-assisted thoracoscopic surgery for pulmonary sequestration},
	journal = {Journal of Thoracic Disease},
	volume = {5},
	number = {1},
	year = {2013},
	keywords = {},
	abstract = {Objective: To analyze the characteristics and technical difficulties of complete video-assisted thoracoscopic surgery (c-VATS) for treatment of pulmonary sequestration operation.
Methods: 25 cases of c-VATS lobectomy for intrapulmonary sequestration performed between January 2009 and May 2012 were reviewed. The 25 patients included 13 (52%) males and 12 (48%) females, with a mean age of 34.7 years (range, 16-62 years). Preoperative imaging by CT scan and three-dimensional reconstruction of abnormal blood vessels diagnosed 19 cases as pulmonary sequestration, misdiagnosed 1 case as pulmonary cyst syndrome, 4 cases as bronchiectasis and 1 case as benign tumor.
Results: All the patients underwent c-VATS excision, 16 in the left lower lobe, 7 in the right lower lobe, 1 in right middle lobe and 1 extralobar pulmonary sequestration. Vascular abnormality was observed intraoperative including the thoracic aorta in 20 cases, abdominal aorta in 2 cases, phrenic arteries and intercostal artery in 1 cases and thoracic aorta combined with abdominal aorta in 1 case. No conversion to open was achieved in all cases. The mean operating time was 114.2 mins (range, 78-156 mins), the mean blood loss was 228 mL (range, 50-3,000 mL), the mean duration of chest drainage was 3.2 days (range, 2-7 days) and the mean length of post-operative hospital stay was 6.6 days (range, 3-13 days). There was no mortality, without significant postoperative complications, were cured and discharged. Patients were followed up for 2-32 months, mean 21.4 months, with no recurrence.
Conclusions: c-VATS is feasible, effective, and safe in treatment of pulmonary sequestration. It is worthy of clinical application.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/840}
}